Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
204.90Prev. Close
203.60Volume
31,69,076Total traded value
64.13 CrUpper Circuit
222.60Lower Circuit
182.13Fundamentals
| Market Cap | ₹26,884Cr |
| ROE | 1.12% |
| P/E Ratio(TTM) | 273.31 |
| EPS(TTM) | 0.74 |
| P/B Ratio | 3.31 |
| Dividend Yield | 0.07% |
| Industry P/E | 35.13 |
| Book Value | 61.17 |
| Debt to Equity | 0.60 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Piramal Pharma
Piramal Pharma operates across three core areas: developing medicines for other pharma companies (CDMO), providing hospital generics like anesthetics (CHG), and selling over-the-counter consumer healthcare products (PCH). The company's guiding philosophy is to grow its business while also making a positive impact on society, a principle it calls 'Doing Well and Doing Good'. It has a significant global footprint, with a distribution network that reaches more than 100 countries worldwide.;
| Parent Organisation | Piramal Pharma |
| NSE Symbol | PPLPHARMA |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.22 | ||
| Cipla | NA (0.00%) | 23.76 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.66 | ||
| Zydus Lifesciences | NA (0.00%) | 21.48 |